Regorafenib



Indications and Reactions:

Role Indications Reactions
Primary
Colorectal Cancer Metastatic 30.5%
Colorectal Cancer 11.1%
Colon Cancer 8.1%
Hypertension 8.1%
Pain 8.1%
Colon Cancer Metastatic 4.9%
Prophylaxis 4.5%
Gastrointestinal Stromal Tumour 3.6%
Vomiting 2.9%
Constipation 2.7%
Abdominal Pain 2.6%
Diabetes Mellitus 2.5%
Nausea 1.8%
Thrombosis Prophylaxis 1.5%
Anxiety 1.3%
Back Pain 1.3%
Insomnia 1.2%
Adenocarcinoma Of Colon 1.1%
Gastrooesophageal Reflux Disease 1.0%
Urinary Tract Infection 1.0%
Renal Failure Acute 9.9%
Weight Decreased 9.9%
General Physical Health Deterioration 8.8%
Palmar-plantar Erythrodysaesthesia Syndrome 7.7%
Rash 6.6%
Thrombocytopenia 6.6%
Dehydration 5.5%
Vomiting 5.5%
Toxic Skin Eruption 4.4%
Death 3.3%
Dyspnoea 3.3%
Metastases To Central Nervous System 3.3%
Myocardial Infarction 3.3%
Pancreatitis 3.3%
Pneumonia 3.3%
Pulmonary Embolism 3.3%
Pyrexia 3.3%
Stomatitis 3.3%
Subileus 3.3%
Atrial Fibrillation 2.2%
Secondary
Colon Cancer 33.3%
Colorectal Cancer Metastatic 21.4%
Colorectal Cancer 11.4%
Colon Cancer Metastatic 7.4%
Hypertension 4.2%
Vomiting 3.6%
Pain 3.1%
Gastrointestinal Stromal Tumour 2.3%
Prophylaxis 2.2%
Spinal Pain 1.8%
Diabetes Mellitus 1.5%
Adenocarcinoma Of Colon 1.4%
Hepatocellular Carcinoma 1.4%
Abdominal Pain 1.3%
Constipation 1.0%
Thrombosis Prophylaxis 0.8%
Hypercholesterolaemia 0.6%
Back Pain 0.5%
Central Venous Catheterisation 0.5%
Anxiety 0.4%
Myocardial Infarction 14.2%
Tachycardia Paroxysmal 12.7%
Renal Failure Acute 9.0%
Pulmonary Embolism 7.5%
Palmar-plantar Erythrodysaesthesia Syndrome 5.7%
Thrombophlebitis Superficial 5.7%
Pneumonia 4.7%
Death 4.2%
Neurofibromatosis 4.2%
Wound Dehiscence 4.2%
Atrial Fibrillation 3.8%
Dehydration 3.3%
General Physical Health Deterioration 3.3%
Weight Decreased 3.3%
Encephalopathy 2.8%
Liver Abscess 2.8%
Small Intestinal Obstruction 2.8%
Pyrexia 1.9%
Rash 1.9%
Stomatitis 1.9%
Concomitant
Colorectal Cancer Metastatic 23.5%
Product Used For Unknown Indication 11.8%
Atrial Fibrillation 5.9%
Blood Iron Decreased 5.9%
Cerebrovascular Accident Prophylaxis 5.9%
Colorectal Cancer 5.9%
Eye Pruritus 5.9%
Hypersensitivity 5.9%
Lacrimation Increased 5.9%
Metastatic Neoplasm 5.9%
Neoplasm Malignant 5.9%
Pulmonary Embolism 5.9%
Rhinorrhoea 5.9%
Disease Progression 25.0%
Drug Ineffective 25.0%
Rectal Haemorrhage 25.0%
Vision Blurred 25.0%
Interacting
Colorectal Cancer Metastatic 66.7%
Arrhythmia 16.7%
Atrial Fibrillation 16.7%
Thyroid Disorder 100.0%